Murugesan Manoharan, MD
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (58.9%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 71.0% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2024 at $4,365 and has fallen 61.0% since, to $1,704 in 2025.
Across 42 payments — averaging $293.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$9K
- Medtronic$1K
- Angiodynamics, Inc.$1K
- Covidien LP$575
- Boston Scientific$203
- Olympus America Inc.$146
- plus $420 from 9 others
Across 73 payments — averaging $3583.20 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Janssen Research & Development, LLC$234K
- Angiodynamics, Inc.$15K
- Medtronic$12K
What the payments were for
- Consulting fees$1,77514%
- Travel & lodging$2,21618%
- Food & beverage$1,0779%
- Education$7,25059%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 18 | $8,745 |
| Medtronic | 1 | $1,200 |
| Angiodynamics, Inc. | 4 | $1,029 |
| Covidien LP | 1 | $575 |
| Boston Scientific | 2 | $203 |
| Olympus America Inc. | 1 | $146 |
| 180 Medical, Inc. | 2 | $85 |
| Merck | 4 | $84 |
| Tempus AI, Inc | 1 | $75 |
| Ferring Pharmaceuticals Inc. | 3 | $56 |
| Osprey Medical Inc | 1 | $49 |
| Blue Earth Diagnostics | 1 | $24 |
| Sumitomo Pharma America, Inc. | 1 | $18 |
| Pfizer | 1 | $17 |
| Coloplast | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DA VINCI SP$4,500
- Da Vinci Surgical System$4,043
- Nanoknife$991
- LigaSure$575
- Soltive$146
- Olympus$146
- SPACEOAR VUE$103
How this compares
$12,318 in reported general payments places this provider in the 80th percentile of 935 urology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 125 | $1,409 |
| Silodosin | 11 | $906 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 23 | $427 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 157 | $410 |
| Finasteride | 13 | $260 |
| Sildenafil Citrate | 23 | $113 |
| Ciprofloxacin Hcl | 14 | $36 |
Paid to pharmacies, not to this prescriber.
Other urology in Miami
- Mark Anthony GonzalgoMiami$1M
- Daniel MartinezMiami$133K
- Emad IbrahimMiami$85K
- Sanoj PunnenMiami$48K
- Ahmed EldefrawyMiami$47K
- Bruce KavaMiami$44K
- Paul PeritoCoral Gables$3.6M
- Scott SellingerTallahassee$2.3M
- Edward GheilerHialeah$655K
- Rolando RiveraNaples$437K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.